Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2248)
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
8,320
Price
$58.30
Total Value
$485.06K
Shares Held After
15,426,989
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
41,178
Price
$57.13
Total Value
$2.35M
Shares Held After
15,435,309
% of Holdings
0.3%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
37,711
Price
$56.51
Total Value
$2.13M
Shares Held After
15,476,487
% of Holdings
0.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
9,271
Price
$55.38
Total Value
$513.43K
Shares Held After
15,514,198
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
9,130
Price
$59.23
Total Value
$540.77K
Shares Held After
8,775,283
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
2,080
Price
$58.30
Total Value
$121.26K
Shares Held After
8,784,413
% of Holdings
0.0%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
10,293
Price
$57.13
Total Value
$588.04K
Shares Held After
8,786,493
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
9,430
Price
$56.51
Total Value
$532.89K
Shares Held After
8,796,786
% of Holdings
0.1%
Protara Therapeutics, Inc. (TARA)
Shefferman Jesse — Director
Shares
215,687
Price
$4.09
Total Value
$882.16K
Shares Held After
721,832
% of Holdings
23.0%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
2,317
Price
$55.38
Total Value
$128.32K
Shares Held After
8,806,216
% of Holdings
0.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$28.02
Total Value
$210.15K
Shares Held After
26,250
% of Holdings
22.2%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
42,350
Price
$25.21
Total Value
$1.07M
Shares Held After
0
% of Holdings
100.0%
BillionToOne, Inc. (BLLN)
ten Bosch John Roderick — SVP of Laboratory Operations
Shares
1,416
Price
$120.00
Total Value
$169.92K
Shares Held After
33,552
% of Holdings
4.0%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
25,000
Price
$2.60
Total Value
$65.00K
Shares Held After
373,322
% of Holdings
6.7%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Climb Bio, Inc. (CLYM)
Brennan Aoife — Director
Shares
30,902
Price
$13.17
Total Value
$406.98K
Shares Held After
87,731
% of Holdings
26.0%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Adaptive Biotechnologies Corp (ADPT)
BENZENO SHARON — Chief Commercial Ofc Imm Med
Shares
154,768
Price
$21.14
Total Value
$3.27M
Shares Held After
221,278
% of Holdings
41.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
40,702
Price
$21.14
Total Value
$860.44K
Shares Held After
975,931
% of Holdings
4.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
51,756
Price
$21.14
Total Value
$1.09M
Shares Held After
1,344,719
% of Holdings
3.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
102,969
Price
$21.14
Total Value
$2.18M
Shares Held After
4,476,487
% of Holdings
2.2%
Omada Health, Inc. (OMDA)
Cook Steven L. — Chief Financial Officer
Shares
17,950
Price
$21.07
Total Value
$378.17K
Shares Held After
115,409
% of Holdings
13.5%
Omada Health, Inc. (OMDA)
Gracey Craig — Chief Accounting Officer
Shares
2,083
Price
$21.00
Total Value
$43.74K
Shares Held After
858
% of Holdings
70.8%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
47,467
Price
$5.04
Total Value
$239.23K
Shares Held After
0
% of Holdings
100.0%
GALECTIN THERAPEUTICS INC (GALT)
Shlevin Harold H. — Director
Shares
22,268
Price
$5.04
Total Value
$112.23K
Shares Held After
6,500
% of Holdings
77.4%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
2,178
Price
$35.18
Total Value
$76.62K
Shares Held After
793
% of Holdings
73.3%
Teladoc Health, Inc. (TDOC)
Bliss Kelly — President, U.S. Group Health
Shares
2,500
Price
$8.50
Total Value
$21.25K
Shares Held After
89,878
% of Holdings
2.7%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
1,649
Price
$75.00
Total Value
$123.67K
Shares Held After
52,173
% of Holdings
3.1%
CareDx, Inc. (CDNA)
Hanna John Walter JR — Director
Shares
39,900
Price
$29.24
Total Value
$1.17M
Shares Held After
661,959
% of Holdings
5.7%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
40
Price
$153.00
Total Value
$6.12K
Shares Held After
1,881,336
% of Holdings
0.0%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
46,663
Price
$152.20
Total Value
$7.10M
Shares Held After
1,881,376
% of Holdings
2.4%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
70,513
Price
$151.47
Total Value
$10.68M
Shares Held After
1,928,039
% of Holdings
3.5%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
25,812
Price
$150.53
Total Value
$3.89M
Shares Held After
1,998,552
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,024
Price
$107.76
Total Value
$325.87K
Shares Held After
466,077
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,318
Price
$106.63
Total Value
$247.17K
Shares Held After
469,101
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
848
Price
$105.78
Total Value
$89.70K
Shares Held After
471,419
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
19,093
Price
$107.76
Total Value
$2.06M
Shares Held After
2,412,747
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,613
Price
$106.63
Total Value
$1.56M
Shares Held After
2,431,840
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,471
Price
$105.78
Total Value
$578.72K
Shares Held After
2,446,453
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Krishnan Mahesh — Director
Shares
7,304
Price
$75.00
Total Value
$547.80K
Shares Held After
14,462
% of Holdings
33.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
157
Price
$111.20
Total Value
$17.46K
Shares Held After
461,794
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,199
Price
$110.67
Total Value
$132.69K
Shares Held After
461,951
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,239
Price
$109.75
Total Value
$135.98K
Shares Held After
463,150
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,688
Price
$108.28
Total Value
$182.78K
Shares Held After
464,389
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
907
Price
$111.20
Total Value
$100.86K
Shares Held After
2,385,747
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,602
Price
$110.67
Total Value
$841.31K
Shares Held After
2,386,654
% of Holdings
0.3%
Showing 101–150 of 2248 transactions (page 3 of 45)